I-Mab (纳斯达克:IMAB)将于2025年10月30日转型为Novabridge Biosciences (纳斯达克:NBP),全新品牌和标志将体现向全球生物科技平台的战略转型

美股速递
Oct 29

I-Mab(纳斯达克:IMAB)将于2025年10月30日转型为Novabridge Biosciences(纳斯达克:NBP),全新品牌和标志将体现向全球生物科技平台的战略转型。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10